In vitro release performance and analgesic activity of endomorphin-1 loaded nanoparticles

Pharmazie

Volumn 61, Issue 5, 2006, Pages 450-452

  Liu, Hui ^a   Ni, Jingman ^a   Wang, Rui ^a  

^a LANZHOU UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ENBUCRILATE; ENDOMORPHIN 1; NANOPARTICLE; POLYSORBATE 80; SURFACTANT;

ANALGESIC ACTIVITY; ANIMAL EXPERIMENT; ARTICLE; BLOOD BRAIN BARRIER; CONTROLLED STUDY; DRUG ABSORPTION; DRUG COATING; DRUG DELIVERY SYSTEM; DRUG HALF LIFE; DRUG RELEASE; DRUG TRANSPORT; IN VITRO STUDY; MOUSE; NONHUMAN; SLOW DRUG RELEASE; TAIL FLICK TEST;

ANALGESICS, OPIOID; ANIMALS; CHEMISTRY, PHARMACEUTICAL; EXCIPIENTS; MICE; MICROSCOPY, ELECTRON, TRANSMISSION; NANOSTRUCTURES; OLIGOPEPTIDES; PAIN MEASUREMENT; POLYSORBATES; SUSPENSIONS;

EID: 33646557640     PISSN: 00317144     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (13)

1. Banks WA, Kastin AJ, Barrera CM (1991) Delivering peptides to the central nervous system: Dilemmas and strategies. Pharm Res 8: 1345-1350.
2. Bigon E, Boarato E, Bruni A, Leon A, Toffano G (1979) Pharmacological effects of phosphatidylserine liposomes: regulation of glycolysis and energy level in brain. Br J Pharmacol 66: 167-174.
3. Gentry CL, Egleton RD, Gillespie T, Abbruscato TJ, Bechowski HB, Hruby VJ, Davis TP (1999) The effect of halogenation on blood-brain barrier permeability of a novel peptide drug. Peptides 20: 1229-1238.
4. Hau VS, Huber JD, Campos CR, Lipkowski AW, Misicka A, Davis TP (2002) Effect of guanidino modification and proline substitution on the in vitro stability and blood-brain barrier permeability of endomorphin II. J Pharm Sci 91: 2140-2149.
5. Kastin AJ, Fasold MB, Smith RR, Homer KA, Zadina JE (2001) Saturable brain-to-blood transport of endomorphins. Exp Brain Res 139: 70-75.
6. Kreuter J, Alyautdin RN, Kharkevich DA, Ivanov AA (1995) Passage of peptides through the blood-brain barrier with colloidal polymer particles (nanoparticles). Brain Res. 674: 171-174.
7. Rapoport SI (1996) Modulation of blood-brain barrier permeability. J Drug Target 3: 417-425.
8. Schroeder U, Sommerfeld P, Sabel BA (1998) Efficacy of oral dalargin-loaded nanoparticle delivery across the blood-brain barrier. Peptides 19: 777-780.
9. Somogyvari-Vigh A, Kastin AJ, Liao J, Zadina JE, Pan W (2004) Endomorphins exit the brain by a staturable efflux system at the basolateral surface of cerebral endothelial cells. Exp Brain Res 156: 224-230.
10. Tröster SD, Müller U, Kreuter J (1990) Modification of the body distribution of poly (methyl methacrylate) nanoparticles in rats by coating with surfactants. Int J Pharm 61: 85-100.
11. Tokes ZA, St Peteri AK, Todd JA (1980) Availability of liposome content to the nervous system. Liposomes and the blood-brain barrier. Brain Res 188: 282-286.
12. Zadina JE, Hackler L, Ge LJ, Kastin AJ (1997) A potent and selective endogenous agonist for the μ-opioid receptor. Nature 386: 499-502.
13. Zhou X, Huang L (1992) Targeted delivery of DNA by liposomes and polymers. J Control Release 19: 269-274.